Safety, Tolerability, and Pharmacokinetics of GMDTC for Cadmium Poisoning: A Randomized Phase 1a/1b Trial.

Saved in:
Bibliographic Details
Title: Safety, Tolerability, and Pharmacokinetics of GMDTC for Cadmium Poisoning: A Randomized Phase 1a/1b Trial.
Authors: Ren X; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China.; School of Public Health, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China., Hu W; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China., Deng X; Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China., Ma R; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China., Pei F; Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China., Chen X; School of Public Health, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China., Wang X; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China., Tang J; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China., Lai Y; Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China., Pan S; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China., Zhong Z; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China., Fu S; Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China., Yuan H; Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China., Yuan J; Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China., Huang C; Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China., Zeng Y; Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, China., Ying X; School of Public Health, Zhejiang Chinese Medical University, Zhejiang, Hangzhou, China., Dong G; School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China., Zhang J; School of Public Health, Sun Yat-sen University, Guangzhou, Guangdong, China., Zhao J; Research Center of Occupational Medicine, Peking University Third Hospital, Beijing, China., Lin K; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China.; Department of Psychiatry and Behavioral Sciences, School of Medicine, The Chinese University of Hong Kong, Shenzhen (CUHK-Shenzhen), Shenzhen, China., Tang X; Guangdong Jianersheng Pharmaceutical Technology Co., Ltd., Zhuhai, Guangdong, China.
Source: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2026 Jul; Vol. 120 (1), pp. 160-167. Date of Electronic Publication: 2026 Mar 31.
Publication Type: Journal Article; Randomized Controlled Trial; Clinical Trial, Phase I
Journal Info: Publisher: Wiley Country of Publication: United States NLM ID: 0372741 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-6535 (Electronic) Linking ISSN: 00099236 NLM ISO Abbreviation: Clin Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1532-6535
DOI:10.1002/cpt.70275